Filing Details

Accession Number:
0001144204-12-035702
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-06-20 21:13:10
Reporting Period:
2012-05-15
Filing Date:
2012-06-20
Accepted Time:
2012-06-20 21:13:10
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1077183 Neogenomics Inc NGNM Services-Testing Laboratories (8734) 742897368
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1032874 J Stephen Clearman 2 Executive Drive, Suite 585
Fort Lee NJ 07024
No No Yes No
1220338 Kinderhook, Lp 2 Executive Drive, Suite 585
Fort Lee NJ 07024
No No Yes No
1266402 Kinderhook Gp Llc 2 Executive Drive, Suite 585
Fort Lee NJ 07024
No No Yes No
1487632 Tushar Shah 2 Executive Drive, Suite 585
Fort Lee NJ 07024
No No Yes No
1542439 Kinderhook Partners, Llc 2 Executive Drive, Suite 585
Fort Lee NJ 07024
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.001 Acquisiton 2012-06-18 11,600 $1.64 4,775,897 No 4 P Direct
Common Stock, Par Value $0.001 Acquisiton 2012-06-19 5,000 $1.65 4,780,897 No 4 P Direct
Common Stock, Par Value $0.001 Acquisiton 2012-06-20 67,437 $1.70 4,848,334 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
Footnotes
  1. Mr. Tushar Shah and Mr. Stephen J. Clearman are the co-managing members of Kinderhook GP, LLC (the "General Partner"), which is responsible for making investment decisions with respect to Kinderhook, LP (the "Partnership") as its general partner. In addition, Mr. Shah and Mr. Clearman are the co-managing members of Kinderhook Partners, LLC (the "Investment Adviser"), which serves as the Partnership's investment adviser, and are responsible for making investment recommendations on behalf of the Investment Adviser. As a result, Mr. Shah and Mr. Clearman may be deemed to control the Partnership, the General Partner, and the Investment Adviser, and may be deemed to have a beneficial interest in the shares of Common Stock by virtue of their indirect control of the Partnership's, the General Partner's, and the Investment Adviser's power to vote and/or dispose of the shares of Common Stock.
  2. Mr. Shah and Mr. Clearman disclaim beneficial ownership of the shares of Common Stock except to the extent of his respective pecuniary interest, if any, therein. Kinderhook Partners, LLC and Kinderhook GP, LLC specifically disclaim beneficial ownership in the shares of Common Stock reported herein except to the extent of its pecuniary interest therein, if any.